This case report describes the successful management of a patient with diabetic ketoacidosis, who developed torsades de pointes leading to nine cardiac arrests secondary to intravenous fluconazole administration on a background of hypokalaemia and hypocalcaemia.
DorseyS.T., BibloL.A.Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline. Am J Emerg Med2000; 18: 227–229.
2.
TholakanahalliV.N., PottiA., HanleyJ.F., MerlissA.D.Fluconazole-induced torsade de pointes. Ann Pharmacother2001; 35: 432–434.
3.
TatetsuH., AsouN., NakamuraM., HanaokaN., MatsunoF., HorikawaK.Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia. Am J Hematol2006; 81: 366–369.
4.
PhamC.P., de FeiterP.W., van der KuyP.H.M., van MookW.N.Long QTc interval and torsade de pointes caused by fluconazole. Ann Pharmacother2006; 40: 1456–1461.
5.
HohnloserS.H., KlingenhebenT., SinghB.N.Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med1994; 121: 529–535.
6.
TerrellC.L.Antifungal agents. Part II. The azoles. Mayo Clin Proc1999; 74: 78–100.
7.
YapY.G., CammA.J.Drug induced QT prolongation and torsades de pointes. Heart2003; 89: 1363–1372.
8.
MakkarR.R., FrommB.S., SteinmanR.T., MeissnerM.D., LehmannM.H.Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA1993; 270: 2590–2597.
9.
AnaissieE.J., KontoyiannisD.P., HulsC., VartivarianS.E., KarlC., PrinceR.A.Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis1995; 172: 599–602.
10.
KhazanM., MathisA.S.Probable case of torsades de pointes induced by fluconazole. Pharmacotherapy2002; 22: 1632–1637.
11.
EidenC., PeyriereH., TichitR., CociglioM., AmedroP., BlayacJ-PInherited long QT syndrome revealed by antifungals drug-drug interaction. J Clin Pharm Ther2007; 32: 321–324.
